Antibody and Recombinant Protein CDMO Market
Antibody and Recombinant Protein CDMO Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Antibody and Recombinant Protein CDMO Market Size and Growth
The Antibody and Recombinant Protein CDMO market research reports indicate a steady growth in market conditions, driven by increasing demand for customized therapeutic antibodies and proteins. The market size is projected to reach $15.8 billion by 2026, with a compound annual growth rate of 8.5%. This growth is fueled by advancements in biotechnology and increasing prevalence of chronic diseases.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Batavia Biosciences
◍ Grifols
◍ Cerbios-Pharma SA
◍ HALIX
◍ Biovian Oy
◍ Catalent
◍ Goodwin Biotechnology
◍ Merck
◍ Hangzhou Hs-biopharm
◍ Wuxibiologics
◍ Bioinnobio
◍ Thousand Oaks Biopharmaceuticals
◍ Cerbios-Pharma SA
◍ Eurogentec
◍ HJB
◍ Bibo Pharma
◍ MabPlex International
◍ Genscriptprobio
The Antibody and Recombinant Protein CDMO Market is highly competitive with key players like Merck, Catalent, and Lonza leading the market. These companies offer a wide range of services from cell line development to manufacturing, helping to grow the market by providing efficient and cost-effective solutions.
- Merck: sales revenue of $17 billion
- Catalent: sales revenue of $2.5 billion
- Lonza: sales revenue of $5.5 billion Request Sample Report
Market Segmentation
By Application
◍ Pharmaceutical Company
◍ Biotechnology Company
◍ Generic Company
By Product
◍ Antibody CDMO
◍ Recombinant Protein CDMO
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients